Cantor Fitzgerald Lowers Earnings Estimates for CG Oncology
CG Oncology, Inc. (NASDAQ:CGON - Free Report) - Equities research analysts at Cantor Fitzgerald cut their FY2025 earnings per share estimates for shares of CG Oncology in a research report issued to clients and investors on Monday, March 31st. Cantor Fitzgerald analyst J. Schimmer now anticipates.
Publicado el: 2025-04-03 10:18:06
Autor: lulegacy, Fuente: lulegacy
Compartir: 
